These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1732132

  • 1. Opposite effects of cholestyramine and loxiglumide on gallbladder dynamics in humans.
    Palasciano G, Portincasa P, Belfiore A, Baldassarre G, Albano O.
    Gastroenterology; 1992 Feb; 102(2):633-9. PubMed ID: 1732132
    [Abstract] [Full Text] [Related]

  • 2. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors.
    Clavé P, González A, Moreno A, López R, Farré A, Cussó X, D'Amato M, Azpiroz F, Lluís F.
    Gastroenterology; 1998 Sep; 115(3):597-604. PubMed ID: 9721157
    [Abstract] [Full Text] [Related]

  • 3. Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.
    Masclee AA, Jansen JB, Rovati LC, Lamers CB.
    Dig Dis Sci; 1993 Oct; 38(10):1889-92. PubMed ID: 8404410
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhancement of gallbladder emptying in gallstone patients after oral cholestyramine.
    Portincasa P, Di Ciaula A, Palmieri VO, Baldassarre G, Palasciano G.
    Am J Gastroenterol; 1994 Jun; 89(6):909-14. PubMed ID: 8198104
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C, Heintges T, Rovati L, Strohmeyer G.
    Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
    Thimister PW, Hopman WP, Loualidi A, Rosenbusch G, Willems HL, Trijbels FJ, Jansen JB.
    Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
    [Abstract] [Full Text] [Related]

  • 11. Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans.
    Hidalgo L, Clavé P, Estorch M, Rodríguez-Espinosa J, Rovati L, Greeley GH, Capellà G, Lluís F.
    Neurogastroenterol Motil; 2002 Oct; 14(5):519-25. PubMed ID: 12358680
    [Abstract] [Full Text] [Related]

  • 12. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.
    Fried M, Schwizer W, Beglinger C, Keller U, Jansen JB, Lamers CB.
    Diabetologia; 1991 Oct; 34(10):721-6. PubMed ID: 1959704
    [Abstract] [Full Text] [Related]

  • 13. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J, Niederau M, Lüthen R, Niederau C.
    Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
    [Abstract] [Full Text] [Related]

  • 14. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Rovati L, Setnikar I.
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [Abstract] [Full Text] [Related]

  • 15. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA, de Boer SY, Lam WF, Rovati LC, Lamers CB, Masclee AA.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE, Creutzfeldt W, Höcker M, Choudhury AR, Nustede R, Schleser A, Nitsche R, Rovati LC, Schafmayer A, Fölsch UR.
    Digestion; 1990 Dec; 46 Suppl 2():232-9. PubMed ID: 2262057
    [Abstract] [Full Text] [Related]

  • 17. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K, Saito T, Saeki M, Ninomiya K, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [Abstract] [Full Text] [Related]

  • 18. Acute intraduodenal bile salt depletion leads to strong gallbladder contraction, altered antroduodenal motility and high plasma motilin levels in humans.
    Portincasa P, Peeters TL, van Berge-Henegouwen GP, van Solinge WW, Palasciano G, van Erpecum KJ.
    Neurogastroenterol Motil; 2000 Oct; 12(5):421-30. PubMed ID: 11012942
    [Abstract] [Full Text] [Related]

  • 19. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE, Creutzfeldt W, Schleser A, Choudhury AR, Nustede R, Höcker M, Nitsche R, Sostmann H, Rovati LC, Fölsch UR.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [Abstract] [Full Text] [Related]

  • 20. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.
    Koop I, Dorn S, Koop H, Witzleb S, Beglinger C, Schafmayer A, Arnold R.
    Dig Dis Sci; 1991 Nov; 36(11):1625-32. PubMed ID: 1935502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.